WO1988007869A3 - ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION - Google Patents
ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION Download PDFInfo
- Publication number
- WO1988007869A3 WO1988007869A3 PCT/BE1988/000011 BE8800011W WO8807869A3 WO 1988007869 A3 WO1988007869 A3 WO 1988007869A3 BE 8800011 W BE8800011 W BE 8800011W WO 8807869 A3 WO8807869 A3 WO 8807869A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gamma
- interferon
- antibodies
- therapeutic application
- immunoglobulin
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 206010063094 Cerebral malaria Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229960003130 interferon gamma Drugs 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Immunoglobulin with neutralizing antibody activity against interferon-gamma of man or of an animal species for use as a therapeuthic agent, as an active substance for inhibiting inflammatory reactions, or preventing or inhibiting cerebral malaria, and medical or veterinary preparation comprising immunoglobulin acceptable excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8700927 | 1987-04-16 | ||
NL8700927A NL8700927A (en) | 1987-04-16 | 1987-04-16 | ANTI-INTERFERON GAMMA ANTIBODIES; AND THEIR THERAPEUTIC APPLICATION. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1988007869A2 WO1988007869A2 (en) | 1988-10-20 |
WO1988007869A3 true WO1988007869A3 (en) | 1988-11-17 |
Family
ID=19849883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BE1988/000011 WO1988007869A2 (en) | 1987-04-16 | 1988-04-18 | ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION |
Country Status (2)
Country | Link |
---|---|
NL (1) | NL8700927A (en) |
WO (1) | WO1988007869A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
DK195089A (en) * | 1989-04-20 | 1990-10-21 | Morten Bagge Hansen | REGULATORY PROTEINS |
IT1231727B (en) * | 1989-08-11 | 1991-12-21 | Enrico Savoldi | USEFUL PEPTIDES FOR THE DETERMINATION AND PURIFICATION OF ANTIBODIES INTERFERONE RANGE. |
DK96493D0 (en) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | PROCEDURE FOR INDUCING ANTIBODY RESPONSE TO SELF-PROTEINS AND AUTOVACCINE PROCESSED BY THE PROCEDURE |
US20020025316A1 (en) | 1995-08-18 | 2002-02-28 | Ferguson Mark Williams James | Pharmaceutical composition containing inhibitors of interferon-gamma |
GB2304342A (en) * | 1995-08-18 | 1997-03-19 | Univ Manchester | Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma |
DK1137766T3 (en) | 1998-12-09 | 2006-01-30 | Protein Design Labs Inc | Use of IL-12 antibodies to treat psoriasis |
US7335743B2 (en) | 2002-10-16 | 2008-02-26 | Amgen Inc. | Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088540A2 (en) * | 1982-02-22 | 1983-09-14 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human immune interferon-like polypeptides |
-
1987
- 1987-04-16 NL NL8700927A patent/NL8700927A/en not_active Application Discontinuation
-
1988
- 1988-04-18 WO PCT/BE1988/000011 patent/WO1988007869A2/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088540A2 (en) * | 1982-02-22 | 1983-09-14 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human immune interferon-like polypeptides |
Also Published As
Publication number | Publication date |
---|---|
NL8700927A (en) | 1988-11-16 |
WO1988007869A2 (en) | 1988-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8467767A0 (en) | PHARMACEUTICAL PREPARATIONS WITH ANTIMICROBIAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION | |
NO882406D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE URINE AND CARBAMATE COMPOUNDS. | |
ZA928171B (en) | Pest control system | |
RU93032613A (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION | |
CA2291144A1 (en) | Topical treatment of psoriasis using neutralizing antibodies to il-8 | |
WO1988007869A3 (en) | ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION | |
AU8439998A (en) | Compounds | |
EP0019403A3 (en) | Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal | |
AU591046B2 (en) | Physiologically active agent for agricultural use | |
IT1178044B (en) | PHARMACEUTICAL ACTIVE AGENT FOR THE TREATMENT OF CEREBRAL DISEASES BASED ON URIDINE | |
DE3164719D1 (en) | Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation | |
GR860009B (en) | Preparations with retardable activity method for their preparation thereof and agent for human and especially veterinary application | |
ZA845682B (en) | Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
AU591017B2 (en) | Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient | |
DK0659341T3 (en) | Solid insecticide preparation | |
DE68901172D1 (en) | (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT. | |
ATE106732T1 (en) | MEDICATION PREPARATION CONTAINING STIGMASTA-4-EN-3-ONE AND USE THEREOF. | |
NO304518B1 (en) | Benzimidazoles, their use for the manufacture of a medicament, and pharmaceutical preparations comprising them | |
AU2366388A (en) | A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect | |
BR9710629A (en) | Pharmaceutical composition Process for its preparation Compound for use as a therapeutic agent and use and use of a compound | |
Kamat | Effects of small doses of anticholinergic agent on EEG auditory evoked responses and behavior of cats. | |
AU1370188A (en) | Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance | |
AU632287C (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans | |
AU4183589A (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG |